Research and Markets: Bleeding and Clotting Disorders-Pipeline Insights -- Developing Strategic Initiatives to Support Your Drug Development Activities

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/l9g4qd/bleeding_and) has announced the addition of the "Bleeding And Clotting Disorders-Pipeline Insights" report to their offering.

This Bleeding And Clotting Disorders-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Bleeding And Clotting Disorders. This report provides information on the therapeutic development based on the Bleeding And Clotting Disorders dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Bleeding And Clotting Disorders.
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information.
  • Coverage of the Bleeding And Clotting Disorders pipeline on the basis of target, MOA, route of administration, technology involved and molecule type.
  • The report reviews key players involved in the therapeutics development for Bleeding And Clotting Disorders and also provides company profiling.
  • The report also gives the information of dormant and discontinued pipeline projects.
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages.
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type.

Key Topics Covered:

  • Bleeding And Clotting Disorders Overview
  • Bleeding And Clotting Disorders Pipeline Therapeutics
  • Bleeding And Clotting Disorders Therapeutics under Development by Companies
  • Bleeding And Clotting Disorders Late Stage Products (Filed and Phase III)
  • Comparative Analysis
  • Bleeding And Clotting Disorders Mid Clinical Stage Products (Phase II)
  • Comparative Analysis
  • Bleeding And Clotting Disorders Early Clinical Stage Products (Phase I and IND Filed)
  • Comparative Analysis
  • Bleeding And Clotting Disorders Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Drug Candidate Profiles
  • Bleeding And Clotting Disorders - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Bleeding And Clotting Disorders - Discontinued Products
  • Bleeding And Clotting Disorders - Dormant Products
  • Companies Involved in Therapeutics Development for Bleeding And Clotting Disorders

For more information visit http://www.researchandmarkets.com/research/l9g4qd/bleeding_and

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals